Clinical trial
"Prospective, Randomized, Multi-Center, Efficacy Non-inferiority Study of MEDIHONEY® Gel Versus Collagenase for Wound Debridement"
NCT02482948 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "Prospective, Randomized, Multi-Center, Efficacy Non-inferiority Study of MEDIHONEY® Gel Versus Collagenase for Wound Debridement"
- Lead sponsor
- Integra LifeSciences Corporation
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2015
- Completion date
- March 31, 2017
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ulcer, wounds